Skip to main content

Table 2 Complications during study period and outcome related to troponin and copeptin values

From: The combination of high sensitivity troponin T and copeptin facilitates early rule-out of ACS: a prospective observational study

 

hsTnT ≤ 14 and Copeptin < 14

hsTnT > 14 or Copeptin ≥ 14

hsTnT > 14 and Copeptin ≥ 14

All

Total number of patients

n = 204

n = 161

n = 113

n = 478

Complications

    

Heartfailure demandning treatment

3 (2)

9 (6)

17 (15)

29 (6)

Major bleeding

2 (1)

3 (2)

7 (6)

12 (3)

Malign arrythmia

3 (2)

3 (2)

8 (7)

14 (3)

Outcome during hospital stay

    

ACS

18 (9)

42 (26)

47 (42)

107 (22)

NSTEMI

3 (2)

30 (19)

37 (33)

70 (14)

Unstable angina pectoris

15 (7)

12 (7)

10 (9)

37 (8)

Coronary angiography with significant stenosis

18 (9)

35 (22)

36 (32)

89 (19)

Coronary angiography without significant stenosis

8 (4)

17 (11)

5 (4)

30 (6)

PCI

11 (5)

23 (14)

27 (24)

61 (13)

CABG

7 (3)

9 (6)

9 (8)

25 (5)

Cardiovascular death

0 (0)

0 (0)

1 (1)

1 (0,2)

Non cardiovascular death

0 (0)

0 (0)

4 (4)

4 (1)

Outcome after 60 days of follow up

    

ACS during follow up, excluding hospital stay

1 (0,5)

4 (2)

4 (4)

9 (2)

Coronary angiography with significant stenosis during follow up

0 (0)

3 (2)

2 (2)

5 (1)

PCI during follow up

0 (0)

0 (0)

1 (1)

1 (0)

CABG during follow up

0 (0)

3 (2)

0 (0)

3 (0,5)

Death during follow up, excluding hospital stay

0 (0)

0 (0)

4 (4)

4 (1)

Combined endpoint

19 (9)

45 (28)

55 (49)

119 (25)

  1. ACS acute coronary syndrome, NSTEMI non ST-elevation myocardial infarction, PCI percutaneus coronary intervention, CABG coronary artery bypass grafting.
  2. Data presented as n (%) of patients. Complications are defined in methods. A combined endpoint of ACS, non-elective PCI, non-elective CABG and death of all causes was used.
  3. Troponin is presentetd in the unit ng/L and copeptin in pmol/L.